Core Viewpoint - POMDOCTOR LIMITED has successfully completed its initial public offering (IPO) with the underwriter exercising the option to purchase an additional 750,000 American Depositary Shares (ADSs) at a price of $4.00 per ADS, resulting in total gross proceeds of $23,000,016 before expenses [1]. Group 1: Offering Details - The IPO included an over-allotment option that was fully exercised, leading to the issuance of 750,000 additional ADSs [1]. - The total gross proceeds from the offering, including the over-allotment, amounted to $23 million [1]. - The ADSs began trading on the Nasdaq Global Market under the ticker symbol "POM" on October 8, 2025 [1]. Group 2: Company Overview - POMDOCTOR LIMITED is a leading online medical services platform in China, focusing on chronic disease management and pharmaceutical services [4]. - The company ranks sixth in China's Internet hospital market based on the number of contracted doctors as of 2022 [4]. - POMDOCTOR aims to enhance the efficiency and transparency of the healthcare value chain by connecting patients, doctors, and pharmaceutical products [4].
POMDOCTOR LIMITED Announces Full Exercise and Closing of Underwriter's Over-Allotment Option